Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

limedika, uab - famotidinas - milteliai ir tirpiklis injekciniam tirpalui - 20 mg - famotidine

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

lex ano, uab - famotidinas - milteliai ir tirpiklis injekciniam tirpalui - 20 mg - famotidine

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

lex ano, uab - famotidinas - milteliai ir tirpiklis injekciniam ar infuziniam tirpalui - 20 mg - famotidine

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

astrazeneca ab - saxagliptin - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatinibas - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antinavikiniai vaistai - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

amgen europe bv - sotorasib - karcinoma, nesmulkiųjų ląstelių skausmas - antinavikiniai vaistai - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatitas c, lėtinis - antivirusiniai vaistai sisteminiam naudojimui - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 ir 5.

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

gilead sciences ireland uc - ledipasvir, sofosbuvir - hepatitas c, lėtinis - antivirusiniai vaistai sisteminiam naudojimui - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 ir 5. hepatito c viruso (hcv) genotipo-konkrečios veiklos, žr. skirsnius 4. 4 ir 5.

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitas c, lėtinis - antivirusiniai vaistai sisteminiam naudojimui - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (žr. skirsnius 4. 2, 4. 4 ir 5.

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

norameda, uab - dazatinibas - plėvele dengtos tabletės - 20 mg - dasatinib